The newly founded Research Topic “Immunology, Infection and Cancer” focuses on the interactions of pathogens and the immune system and how they drive carcinogenesis, with the aim to develop novel immunotherapeutic approaches to cancer. The Topics missions are twofold:
(i) Understand immune reactivity to and develop effective immunotherapies for cancer through single cell analyses and targeted manipulation of immune cells from development through activation, and
(ii) Decipher pathogen/commensal – host interactions and mechanisms of (sterile) inflammation with the goal to devise prophylactic and therapeutic treatment lowering cancer burden.
We cover basic research to clinical implementation in the priority areas
(i) Immune Cell Development and Differentiation,
(ii) Host-Microbe Interactions in Health and Disease,
(iii) Cancer Inflammation and Immune Microenvironment,
(iv) Vaccine Development and Virotherapy, and
(v) T cell therapies.
In addition to programs to implement novel strategies to prevent and treat cancer at a national and global level via clinical trials, members of the Research Topic promote the transfer of new technologies into therapies through spin-outs.

News from Research Program "Immunology, Infection and Cancer"